Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.

Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M, Costa Rica Vaccine Trial Group
Am J Epidemiol. 2014 180 (6): 599-607

PMID: 25139208 · PMCID: PMC4157699 · DOI:10.1093/aje/kwu168

MeSH Terms (16)

Adolescent Adult Antibodies, Viral Cervical Intraepithelial Neoplasia DNA, Viral Double-Blind Method Female Human papillomavirus 16 Human papillomavirus 18 Humans Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Serologic Tests Uterine Cervical Neoplasms Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links